Compare Immunovant Inc. Common Stock (IMVT) vs XPO Inc. Common Stock (XPO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs XPO Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.13 (market cap $6.25B), while XPO Inc. Common Stock trades at $179.79 (market cap $21.30B). The key difference: XPO Inc. Common Stock is far larger — about 3.4× Immunovant Inc. Common Stock's market cap, and XPO Inc. Common Stock is more actively traded (897,705 versus 1,755,411). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and XPO Inc. Common Stock for 0 Days on average.
| IMVT | XPO | |
|---|---|---|
Market Cap | $6.25B | $21.30B |
Volume | 1,755,411 | 897,705 |
Sector | Health | Industrials |
52-Week High | $44.96 | $228.37 |
52-Week Low | $17.03 | $123.66 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.35B | $24.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About XPO Inc. Common Stock
XPO provides freight transportation services in North America and Europe. Its operations include less-than-truckload freight transportation and brokerage services supported by a technology platform.
Read more on XPO →
